Sanofi-Aventis makes 18.5 bln dollar bid for US Genzyme
Sunday, August 29, 2010 - 13:28
in Mathematics & Economics
French pharmaceutical group Sanofi-Aventis unveiled Sunday a 18.5 billion dollar (14.5 billion euro) cash bid for US biotechnology firm Genzyme, or 69 dollars per share.